Insight into the metabolic-epigenetic interplay of fumaric acid esters in brain-homing T cells in MS March 25, 2019
Phase III ENGAGE and EMERGE studies of aducanumab in Alzheimer's to end based on futility analysis March 21, 2019
FDA approves Sunosi for excessive daytime sleepiness associated with narcolepsy or OSA March 21, 2019
First subject dosed in phase II study of GRF-6019 in patients with severe Alzheimer's disease March 19, 2019
RSS